SCHEMBL8215437

SCHEMBL8215437

Nc1cc(CS(=O)(=O)c2ccc(F)cc2)nc(-c2ccc(NC(=O)Nc3ccccn3)cc2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 5/20 0.46
MTOR P42345 5/20 0.46
NPC1 O15118 6/20 0.44
RAB9A P51151 6/20 0.44
LMNA P02545 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.42
ADORA3 P0DMS8 1/20 0.42
PIM1 P11309 1/20 0.42
ADORA2A P29274 1/20 0.42
ADORA2B P29275 1/20 0.42
ADORA1 P30542 1/20 0.42
FLT3 P36888 1/20 0.42
PIM3 Q86V86 1/20 0.42
AURKB Q96GD4 1/20 0.42
LIMK1 P53667 1/20 0.41
PIK3R1 P27986 2/20 0.40
KMT2A Q03164 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8091796 0.84 NPC1 (0.49) PIK3CAMTORNPC1RAB9ALMNA
SCHEMBL8218182 0.84 PIK3CA (0.51) PIK3CAMTORNPC1RAB9AADORA3
SCHEMBL8215433 0.84 MTOR (0.49) PIK3CAMTORLMNASMN1; SMN2ADORA3
SCHEMBL8219760 0.83 PIK3CA (0.51) PIK3CAMTORKMT2AMEN1CA12
SCHEMBL8211599 0.82 PIK3CA (0.49) PIK3CAMTORALDH1A1CA12CA1
SCHEMBL8211601 0.81 PIK3CA (0.48) PIK3CAMTORKMT2AMEN1CA12
SCHEMBL8218892 0.81 PIK3CA (0.48) PIK3CAMTORNPC1RAB9ASMN1; SMN2
SCHEMBL11925678 0.80 PIK3CA (0.45) PIK3CAMTORNPC1RAB9ASMN1; SMN2
SCHEMBL8217566 0.80 PIK3CA (0.47) PIK3CAMTORLMNAKMT2AMEN1
SCHEMBL8083683 0.80 NPC1 (0.42) PIK3CAMTORNPC1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008023159-A1 MORPHOLINO PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF PROLIFERATIVE DISORDERS ASTRAZENECA AB (SE) 2008-02-28 WO disclosed